Rethinking wound care
from first principles
A science-driven company developing natural diatomite-based therapeutics for diabetic foot ulcers. Headquartered in Germany, operating in China.
Get in touchA science-first approach to an ancient problem
Diabetic foot ulcers affect millions globally, with limited therapeutic options. We're building a new class of treatment based on natural diatomite — combining decades of safety data with cutting-edge wound biology.
Scientific Foundation
Natural materials, rigorous testing, regulatory expertise.
Global Network
EU-based research & IP, China-based manufacturing & clinical access.
Regulatory Ready
EU MDR Class IIa pathway aligned. NMPA expertise in place.
Physics before chemistry.
Prevention before cure.
We apply mechanical-based wound management using natural materials with proven safety profiles. No novelty-chasing. No experimental compounds.
Natural Materials
Our platform is built on diatomaceous earth — a substance with 30+ years of established human safety data in consumer health markets across Europe.
Precision Engineering
Natural doesn't mean uncontrolled. We specify exact particle size, purity, and elemental composition to ISO and EU MDR standards.
Dual Geographic Origin
Our formulation leverages two distinct geological sources, each selected for specific therapeutic properties and validated through independent laboratory analysis.
Intellectual Property
Three-patent strategy providing 25–28 years of market protection. Full FTO clearance established. Details available under NDA.
Interested in learning more?
We welcome conversations with investors, clinical partners, and strategic stakeholders. All discussions are conducted under strict confidentiality agreements.